GLP-1RA for prevention of CR outcomes in T2D

Abstract

This meta-analysis of GLP-1RA CVOTs sheds new light on the cardiorenal efficacy of GLP-1RAs in patients with T2D.

Citation
Giugliano D, Maiorino MI, Bellastella G, et al. Diabetes Obes Metab 2019;21:2576–80.